[General practice study confirms a favorable risk benefit profile].
, .
Veronika
V
Schlimpert
D006801:Humans; D001281:Atrial Fibrillation / Q000188:drug therapy; D000069604:Dabigatran / Q000009:adverse effects / Q000627:therapeutic use; D017277:Drug Approval; D058006:General Practice; D006470:Hemorrhage / Q000139:chemically induced; D018570:Risk Assessment; D014859:Warfarin / Q000627:therapeutic use
D000069604:Dabigatran; D014859:Warfarin